NB Data presented here are either national estimates (prevalence of use, opioid drug users) or reported numbers through the EMCDDA indicators (treatment clients, syringes, deaths and HIV diagnosis, drug law offences and seizures). Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.
What are the long-term aims of drug policy in the Czech Republic? How are these aims to be achieved? How is drug policy coordinated at national level?
Understanding the costs of drug-related actions is an important aspect of policy evaluation.
What substances and activities does the Czech Republic control under its drug laws? What are the penalties for offences? How are new psychoactive substances controlled?
How many people in the Czech Republic have ever used drugs? What drugs have they used? How many have used drugs recently? How many are using drugs in highly risky ways?
What are the main infectious diseases linked to drug injecting in the Czech Republic? How many died of drug overdose in the last year? How many drug-related medical emergencies occurred?
What part does prevention play in Czech Republic drug strategy. What are the main prevention approaches used in the country and who do they target?
How does the Czech Republic measure in terms of provision of needle and syringe programmes, peer naloxone programmes, supervised drug consumption rooms and heroin-assisted treatment.
How is the drug treatment system organised in the Czech Republic? How is it financed? How is the provision of treatment divided between inpatient and outpatient settings?
Which authorities are responsible for prison health in the Czech Republic? What forms of drug treatment and harm reduction are provided in prisons, and how widely?
What is done in the Czech Republic to ensure that the prevention and treatment interventions used are effective and provide a good return on public expenditure?
In which areas of study is drug-related research carried out in the Czech Republic? How is this research funded? Are any types of research emphasised in the national drug strategy?
What is known about drug supply and trafficking in the Czech Republic? How pure or strong are the drugs available? What do they cost? What are the main aims of supply reduction efforts?
Key drug statistics for the Czech Republic
Focus on the Czech Republic